A Pilot Study of Pivanex in Patients With Malignant Melanoma

NCT00087477 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: Pivanex

Sponsor

Titan Pharmaceuticals